Herb Greenberg is the editor of Herb Greenberg's Reality Check, a subscription newsletter designed to help investors better manage risk. He writes a daily blog for TheStreet's main free website and contributes to its Real Money's "Columnist Conversation" column as well as being a regular contributor for CNBC.
Greenberg has been a financial journalist for more than 30 years, working most recently as a senior stocks commentator on CNBC's Business Day programming and on CNBC.com. He was also co-president of Greenberg Meritz Research & Analytics. He is a former weekend investor columnist for The Wall Street Journal and a former senior columnist for MartketWatch.
Prior to joining MarketWatch, Greenberg was senior columnist for TheStreet.com. He previously spent 10 years as the "Business Insider" columnist for the San Francisco Chronicle and nearly seven years as Fortune magazine's monthly "Against the Grain" columnist.
He also was the New York financial correspondent for the Chicago Tribune and a financial reporter in its Chicago newsroom. Greenberg has held various positions at other media outlets including Crain's Chicago Business and the St. Paul Pioneer Press.
Greenberg holds a bachelor's degree in journalism from the University of Miami.
Follow Herb Greenberg on Twitter @herbgreenberg.
Carlyle’s deal to buy NBTY, the vitamin company, for $3.8 billion stopped me in my tracks. NBTY has been a long-standing tug-of-war stock between the longs and shorts.
Intel's conference call was about as optimistic and bullish as any I've heard.
Veritas Executive Compensation Consultants recently reviewed the latest batch of proxies and discovered some interesting perks for chief executives.
With Alcoa coming in with better-than-expected results, one thing to keep in mind: It should all be kept in perspective.
As we head into earnings, if your strategy is buying into analyst estimates, here are some helpful tips to remember:
The problems caused by underfunded pension have been swept under the rug for years, but as Ken Hackel points out, that is about to change or should change.
Anytime a company becomes less of what it was, investors need to rethink how it's valued and why they own it. If nothing else, it's an important discussion point that takes nothing away from Berkshire or Warren Buffett.